REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/03/2026
Voltar para busca
Dado oficial do USPTO
MOLECULAR PERFECTION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MOLECULAR PERFECTION
ST13
US500000087866829Classe
5, 25
Pedido
87866829
Registro
6309310
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 25
Data de depósito
06/04/2018
Data de registro
30/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/03/2021
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
29/09/2017
Primeiro uso no comércio
07/01/2019
Código do desenho
4
Tipo de titular
01
Localização do titular
Irvine, CA, US
Examinador
GLASSER, CARYN
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Ashlock, Brett
Representantes
Sophia Sarwar Rutan & Tucker LLP
Classificação técnica
Classes Nice
Classe 5Classe 25
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Therapeuticsmedicinal herbsmedicinal herbs in dried or preserved formmedicinal oils and medicinal plants extracts for pharmaceutical purposes for use in the treatment of painmultiple sclerosisneuropatipahtic painspinal cord injurybladder dysfunctionperipheral neuropathycancer painperi-operative painrheumatoid arthritisinflammatory bowel diseaseulcerative colitisCrohn's diseaseAlzheimer's diseaseneurogenic symptomspsychotic disordersdiseases of the central nervous systemstroke and head injurymotion sickness and chemically induced sicknessspasticityoncologycancer symptomspsychiatric illnessesneurodegenerative diseasesmetabolic disordersobesityobesity associated with type II diabetesbulimiaschizophreniaepilepsyDravet syndromeneonatal hypoxiaseizuresalzheimersbone disordersdrugalcohol and nicotine abuseinflammatory disordersprotection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patientsprotection of beta cells in the treatment of diabetic or pre-diabetic patientsmaintenance of insulin levelsimproved control of blood glucose levelstreatment of type I diabetestreatment of type II diabetes; treatment of multiple sclerosisneuropathic painspinal cord injurybladder dysfunctionperipheral neuropathycancer painperi-operative painrheumatoid arthritisinflammatory bowel diseaseneurogenic symptomspsychotic disordersdiseases of the central nervous systemstroke and head injurymotion sickness and neurodegenerative diseasesmetabolic disordersobesityobesity associated with type II diabetesinflammatory disordersherbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes
Classe 25
Clothingshirtst-shirtshatsvisors and caps being headwearjacketscoatsskirtsheadbands and
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/03/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/02/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/02/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/02/2021
IUAF
USE AMENDMENT FILED
20/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
20/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/07/2020
EX2G
SOU EXTENSION 2 GRANTED
23/07/2020
EXT2
SOU EXTENSION 2 FILED
23/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
23/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2020
EX1G
SOU EXTENSION 1 GRANTED
30/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/04/2020
NREV
NOTICE OF REVIVAL - E-MAILED
23/04/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
23/04/2020
PETG
PETITION TO REVIVE-GRANTED
23/04/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
23/04/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/04/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/04/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
24/02/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
24/02/2020
EXT1
SOU EXTENSION 1 FILED
23/01/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
15/11/2019
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
15/11/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2019
PUBO
PUBLISHED FOR OPPOSITION
28/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/04/2019
ALIE
ASSIGNED TO LIE
22/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/04/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/04/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/04/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/04/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/01/2019
GNFR
FINAL REFUSAL E-MAILED
22/01/2019
CNFR
FINAL REFUSAL WRITTEN
22/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/07/2018
GNRT
NON-FINAL ACTION E-MAILED
24/07/2018
CNRT
NON-FINAL ACTION WRITTEN
24/07/2018
DOCK
ASSIGNED TO EXAMINER
24/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/04/2018
NWAP
NEW APPLICATION ENTERED
10/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOLECULAR PERFECTION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.